Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Panay

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Menopause (New York, N.Y.)|April 29, 2022
The effect of micronized progesterone and medroxyprogesterone acetate in combination with transdermal estradiol on hemostatic biomarkers in postmenopausal women diagnosed with POI and early menopause: a randomized trialMonica Mittal, Paradzai Chitongo, Prasanna Raj Supramaniam, et al.
Post Reproductive Health|April 13, 2025
Feasibility of developing a new tool for assessing vaginal health in women with Genitourinary Syndrome of Menopause; The VAN studyPaula Briggs, Christopher Evans, Steven Lane, et al.
Climacteric : the Journal of the International Menopause Society|December 23, 2025
International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopauseNick Panay, Anna Fenton, Haitham Hamoda, et al.
Psychoneuroendocrinology|October 1, 2021
A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorderTorbjörn Bäckström, Karin Ekberg, Angelica Lindén Hirschberg, et al.
Post Reproductive Health|April 21, 2022
Consensus-led recommendations supporting choice and personalisation of Hormone replacement therapy in menopause carePaula Briggs, Katie Barber, Kathie Cooke, et al.
Maturitas|November 25, 2025
Estetrol for the treatment of moderate to severe vasomotor symptoms in postmenopausal women: The design of the E4COMFORT I and II trialsNick Panay, Tommaso Simoncini, Mélanie Taziaux, et al.
Maturitas|April 21, 2023
Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practiceNick Panay, Rossella E Nappi, Petra Stute, et al.
Maturitas|May 2, 2026
Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled studyTommaso Simoncini, Céline Bouchard, Marie Cloes, et al.
The Oncologist|February 1, 2013
A study to evaluate the cause of bone demineralization in gynecological cancer survivorsChara Stavraka, Kate Maclaran, Hani Gabra, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 17, 2006
Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approachLila E Nachtigall, Rodney J Baber, Ronald Barentsen, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Menopause (New York, N.Y.)|April 29, 2022
The effect of micronized progesterone and medroxyprogesterone acetate in combination with transdermal estradiol on hemostatic biomarkers in postmenopausal women diagnosed with POI and early menopause: a randomized trialMonica Mittal, Paradzai Chitongo, Prasanna Raj Supramaniam, et al.
Post Reproductive Health|April 13, 2025
Feasibility of developing a new tool for assessing vaginal health in women with Genitourinary Syndrome of Menopause; The VAN studyPaula Briggs, Christopher Evans, Steven Lane, et al.
Climacteric : the Journal of the International Menopause Society|December 23, 2025
International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopauseNick Panay, Anna Fenton, Haitham Hamoda, et al.
Psychoneuroendocrinology|October 1, 2021
A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorderTorbjörn Bäckström, Karin Ekberg, Angelica Lindén Hirschberg, et al.
Post Reproductive Health|April 21, 2022
Consensus-led recommendations supporting choice and personalisation of Hormone replacement therapy in menopause carePaula Briggs, Katie Barber, Kathie Cooke, et al.
Maturitas|November 25, 2025
Estetrol for the treatment of moderate to severe vasomotor symptoms in postmenopausal women: The design of the E4COMFORT I and II trialsNick Panay, Tommaso Simoncini, Mélanie Taziaux, et al.
Maturitas|April 21, 2023
Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practiceNick Panay, Rossella E Nappi, Petra Stute, et al.
Maturitas|May 2, 2026
Estetrol (E4) for the treatment of moderate to severe vasomotor symptoms in postmenopausal women - Efficacy and safety results from the phase 3 E4COMFORT I multicenter, placebo-controlled studyTommaso Simoncini, Céline Bouchard, Marie Cloes, et al.
The Oncologist|February 1, 2013
A study to evaluate the cause of bone demineralization in gynecological cancer survivorsChara Stavraka, Kate Maclaran, Hani Gabra, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 17, 2006
Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approachLila E Nachtigall, Rodney J Baber, Ronald Barentsen, et al.
Pageof 8